If you would like more information about clinical trials and the CMV treatment options available during pregnancy, speak with your doctor. If you require further support or assistance, please contact us
Congenital CMV Treatment Options in Newborns
Emerging research shows that antiviral drugs, Ganciclovir
, may help newborns born with symptomatic congenital CMV
These antiviral treatments may prevent or lessen the severity of hearing loss and may improve head and brain growth. Ganciclovir and Valganciclovir are CMV treatment options that can also help combat immediate medical concerns caused by CMV, such as thrombocytopenia
, organ failure (most commonly spleen and/or liver), hepatitis, and pneumonitis. These CMV treatments generally last from six weeks to six months and are administered orally through an IV or PICC line.
Both Ganciclovir and Valganciclovir can have serious side effects, so be sure to consult with a doctor before and during the antiviral treatment period. Newborns receiving these antiviral treatments should their blood counts taken regularly to avoid problems with severe neutropenia
If your baby was born with congenital CMV and you could like more information about antiviral treatments, speak with your child's pediatrician or pediatric infectious disease specialist. If you require further support or assistance, please contact us
Ongoing Interventions & Therapies
If your baby is diagnosed with congenital CMV, be sure to have his or her hearing and vision checked regularly to identify any early onset of hearing or vision loss. Early diagnosis is critical to experiencing long-term developmental successes.
If you are concerned about potential seizure activity, record your baby's behavior and send this information to your pediatrician so he or she may help refer you to a pediatric neurologist consultation. Additional monitoring, including EEG
, may be suggested to properly evaluate your child for seizures.
Additional interventions may help to improve your child's cognitive and physical abilities. In every state, there are programs available for children through the Early Intervention (EI) Program for Infants and Toddlers, as mandated in Part C of the Individuals with Disabilities Education Act (IDEA1
). EI is a federally funded, state-run program that provides support for infants and toddlers with disabilities, or who are at risk for having significant developmental delays. "Disabilities" at this age can range from severe special needs to feeding difficulties to delays in fine motor skills, communication, or muscle developments. EI services may include speech/language therapy, special instruction, occupational therapy, physical therapy, and developmental monitoring.
Ask your child's pediatrician for a referral to your local EI program to determine whether your child should be evaluated for EI services.